References
- De Backer G., Ambrosioni E., Borch‐Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601–10
- Neil H. A., Mant D., Jones L., Morgan B., Mann J. I. Lipid screening: is it enough to measure total cholesterol concentration?. Br Med J 1990; 301: 584–7
- Conroy R. M., Pyörälä K., Fitzgerald A. P., Sans S., Menotti A., De Backer G., et al. Estimation of ten‐year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003
- Grundy S. M., Cleeman J. I., Merz C. N., Brewer H. B., Clark L. T., Hunninghake D. B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720–32
- Behandling med lipidsänkande medel vid prevention av hjärt‐kärlsjukdomar (Treatment with lipid lowering drugs in prevention of cardiovascular diseases). Information från läkemedelsverket (Information from Swedish Medical Product Agency) 2003; 4: 9–68
- Hoeg J. M. Detection and evaluation of dyslipoproteinemia. Endocrinol Metab Clin North Am 1990; 19: 311–20
- Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
- Tremblay A. J., Morrissette H., Gagné J. M., Bergeron J., Gagné C., Couture P. Validation of the Friedewald formula for the determination of low‐density lipoprotein cholesterol compared with beta‐quantification in a large population. Clin Biochem 2004; 37: 785–90
- Zavaroni I., Ardigo D., Massironi P., Gasparini P., Barilli A. L., Vetrugno E., et al. Do coronary heart disease risk factors change over time?. Metabolism 2002; 51: 1022–6
- Kafonek S. D., Derby C. A., Bachorik P. S. Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic. Clin Chem 1992; 38: 864–72
- Smith S. J., Cooper G. R., Myers G. L., Sampson E. J. Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 1993; 39: 1012–22
- Wasenius A., Stugaard M., Otterstad J. E., Frøyshov D. Diurnal and monthly intra‐individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest 1990; 50: 635–42
- Yildirimkaya M., Bil Gi C., Ozata M., Nazaroglu N. K., Gondogan M. A., Kutluay T., et al. Biological variation of serum lipids and lipoproteins in patients with clinically well controlled non‐insulin dependent diabetes mellitus. Endocr J 1996; 43: 345–51
- Law M. R., Wald N. J., Rudnicka A. R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta‐analysis. B Med J 2003; 326: 1423
- Altman D. G., Machin D., Bryant T. N., Gardner T. N. Statistics with confidence. BMJ Publishing, London 2000, 2nd edn